NCT02953288

Brief Summary

To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 1, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 2, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

November 2, 2016

Status Verified

November 1, 2016

Enrollment Period

8 months

First QC Date

November 1, 2016

Last Update Submit

November 1, 2016

Conditions

Thyroid Cancer

Outcome Measures

Primary Outcomes (1)

  • Gene sequencing

    2 weeks

Study Arms (2)

Benign thyroid nodules

Benign thyroid nodules

Thyroid Carcinoma

Thyroid Carcinoma

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with thyroid nodule

You may qualify if:

  • Patient with thyroid nodule

You may not qualify if:

  • Coagulant function abnormality
  • pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Shanghai Tenth People's Hospital

Shanghai, Shanghai Municipality, 200070, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Thyroid tissue

MeSH Terms

Conditions

Thyroid Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Officials

  • Shen Qu

    Sanghai Tenth People's Hospital, Shanghai, China

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Endocrinology

Study Record Dates

First Submitted

November 1, 2016

First Posted

November 2, 2016

Study Start

October 1, 2016

Primary Completion

June 1, 2017

Study Completion

December 1, 2018

Last Updated

November 2, 2016

Record last verified: 2016-11

Locations

CN(1)